Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
47 hedge funds and large institutions have $242M invested in Vigil Neuroscience in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
18% more funds holding
Funds holding: 40 → 47 (+7)
1.85% more ownership
Funds ownership: 70.3% → 72.15% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2% less capital invested
Capital invested by funds: $246M → $242M (-$3.95M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.12M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.63M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$966K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$602K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$3.14M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.38M |
| 3 |
Millennium Management
New York
|
-$699K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$575K |
| 5 |
Morgan Stanley
New York
|
-$404K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$183K | -18,705 | Closed |
|
|
6CM
52
683 Capital Management
New York
| – | -$148K | -15,092 | Closed |
|
|
CC
53
Cannell Capital
Alta,
Wyoming
| – | -$78.8K | -8,044 | Closed |
|
54
UBS Group
Zurich,
Switzerland
| – | -$5.8K | -592 | Closed |
|
VIGL Hedge Fund Activity: Q2 2023 in Review
47 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q2 2023, worth a combined $242M — down 1.6% from $246M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new VIGL positions and 7 closed out — a net gain of 8 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $6.8M. The largest seller was Artal Group, cutting an estimated $3.14M.
- 47 institutional investors held Vigil Neuroscience (VIGL) as of Q2 2023, up from 40 in Q1 2023.
- Funds reported $242M of Vigil Neuroscience stock for Q2 2023, down 1.6% quarter-over-quarter.
- 15 funds opened new Vigil Neuroscience positions in Q2 2023 and 7 closed out, a net change of +8 holders.
- The largest Vigil Neuroscience buyer in Q2 2023 was BlackRock, an estimated $6.8M added.
- The largest Vigil Neuroscience seller in Q2 2023 was Artal Group, an estimated $3.14M sold.
Based on aggregated 13F filings for Q2 2023.